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Introduction
Gut health depends on availability of a large num-
ber of diverse molecules. Many of these molecules
are supplied through the food and made available
in the large intestine (particularly colon) of pet an-
imals by fermentative actions. The colon plays a
major role in host nutrition and welfare through the
activities of its resident microbiota (Manning and
Gibson, 2004). It is the most heavily colonized re-
gion with a total population of 1011-1012 cfu/ml of
contents and therefore, the colonic microbiota is
the predominant target for dietary intervention in
the gut ecology, and consequently, the gut health.
In this regard, dietary-management tools already
exist in the shape of phytochemicals, antioxidants,
probiotic microorganisms, prebiotic oligosaccha-
rides, and synbiotic mixtures of the two. There is
evidence that these tools do work in pet dogs. How-
ever, at present, our picture of the dog GI-tract
ecology is far from complete. Rapid development
of new DNA-based methods is under way for
studying the composition of complex colonic mi-
crobial ecosystem and these have not yet been sys-
tematically applied to the study of pet animals.
Such studies are required if we are to realize the
potential of dietary strategies to alter the colonic
microbiota. Various nutritional and biotechnologi-
cal approaches have been proposed to resolve this
issue. Some of them are discussed below.
Nutritional Approaches
Dogs need a perfectly balanced diet for their opti-
mum health; some fifty nutrients are now consid-
ered essential for dogs, and the quality of a
particular dog food is based on how well it matches
the requirements for each of those fifty nutrients.
The amount of these nutrients must reflect the dog's
size, physiological condition, and health status.
However, the typical pet diet mainly contains high
concentrations of protein, which can lead to in-
creased concentrations of undigested amino acids
and fecal putrefactive compounds in the colon.
Many of these protein catabolites may have nega-
tive influences on gut health. So, the diet should be
adequate and balanced in all respect. Active food
compounds like phytochemicals and antioxidants
can be used as one of the practical approaches to
improve diet.
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Abstract
Gut health is an important facet of well being of pet animals; it is in this context, various nutritional and biotechnological
approaches have been proposed to manipulate the gut health by specifically targeting the colonic microbiota. Nutritional ap-
proaches include supplementation of antioxidants and phytochemicals like flavonoids, isoflavonoids and carotenoids. Biotech-
nological approaches include supplementation of probiotics, prebiotics, synbiotics in the diet and potential application of
molecular tools like fluorescent in situ hybridization, denaturing gradient gel electrophoresis, quantitative dot blot hybridiza-
tion, and restriction fragment length polymorphism etc. in studying the fecal microbiota composition. Post-genomic and re-
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between gut microbiota and host.
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Phytochemicals are present in plant based
foods, e.g. fruits, vegetables and whole grain cere-
als. They constitute a large number of chemically
diverse substances, which are grouped into various
categories like flavonoids, isoflavonoids and
carotenoids. The bioavailability of flavonoids in the
small intestine is generally considered to be small.
Thus a large portion of the ingested flavonoids may
reach the large intestine. In the large intestine, con-
siderable metabolism by the gut microbiota occurs.
In the first step, the bound carbohydrates are
cleaved and used as substrates by the microbiota.
In further steps, the polyphenolic structures are de-
graded. Flavonoid - aglycones have been shown to
potently affect the functional properties of colonic
epithelial cells thereby modulating cell prolifera-
tion, apoptosis and signal transduction in colonic
carcinoma cell lines. Thus the metabolic activity of
the microbiota may have a profound effect on the
biological activity of these compounds in the large
intestine. Carotenoids are lipid-soluble pigments
with a high bioavailability in the small intestine de-
pending on the presence of lipids in the diet. How-
ever, the release of carotenoids from the respective
food matrices depends on the processing condi-
tions. In raw fruits and vegetables, the carotenoid
bioavailability is low. So, the processing of
carotenoid-containing foods, e.g. heat treatment
(cooking), for a large part determines its bioavail-
ability in the small intestine. In the large intestine,
the microbial degradation of dietary fiber con-
tributes to the release of so far unavailable
carotenoids.
Free radicals are a major cause of many degen-
erative diseases of GIT. Epidemiological data and
randomized clinical trials provide ample indica-
tions that antioxidants play a fundamental role in
the prevention of these diseases. They act as scav-
engers of reactive oxygen species and metal chela-
tors that protect cells and reduce oxidative
damages. Brussels sprouts, kale, cabbage, onions,
cauliflower, red beets, cranberries, cocoa, black-
berry, blueberry, red grapes, prunes, and citrus
fruits are the richest sources of antioxidants.
Biotechnological Approaches
The gastrointestinal tract is a multidimensional sys-
tem ideal for an integrated, non-biased, system bi-
ology approach, which could be combined with
clinical and health information to enable debilitat-
ing health issues to be addressed. A true system bi-
ology approach needs to integrate both the host and
microbial components of the gastrointestinal tract,
but as yet these techniques have seen a little appli-
cation in pet animals.
Conceptual Approaches
A dietary prebiotic is a selectively fermented ingre-
dient that results in specific changes, in the com-
position and/or activity of the gastrointestinal
microbiota, thus conferring benefit(s) upon host
health (Roberfroid et al., 2010). It must be partic-
ularly available to some groups of bacteria (of
which bifidobacteria and lactobacilli are considered
indicator organisms) that are beneficial for the
health of the intestine but less available to poten-
tially pathogenic bacteria such as toxin producing
clostridia, proteolytic bacteroides and toxogenic
Escherichia coli (Manning and Gibson, 2004). In
this manner, a ‘healthier’ microbiota composition
can be obtained whereby the bifidobacteria and/or
lactobacilli become predominant in the intestine
and exert possible health-promoting effects. These
prebiotics include resistant non-digestible oligosac-
charides, resistant starch, and non-starch polysac-
charides (dietary fiber).
Probiotics are the ‘live microorganisms which
when administered in adequate amounts confer a
health benefit to the host’ (FAO/WHO, 2002).
Members of the genera Lactobacillus and Bifi-
dobacterium have a long and safe history in the
manufacture of dairy products and are also found
as a part of gastrointestinal microbiota. Probiotics
have been consumed in foods for perhaps thou-
sands of years. However, because of the reported
variability in viability of live bacteria (probiotics)
in food products and during transit through the gas-
trointestinal (GI) tract, the microencapsulation
technology has been developed.
This technology aims at encapsulating a selec-
tive probiotic within starch granules that is then
coated with amylose thereby protecting the bacteria
during processing, storage, and passage through the
gastrointestinal tract (Mylla rinen et al., 1999).
Binding of adherent strains to the resistant starch
core may facilitate encapsulation of the bacteria.
Further investigations are necessary to determine
the degrees of adhesion of bifidobacteria and other
bacteria to different types of resistant starch in the
gastrointestinal tract and the impact of adhesion on
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substrate utilization, colonization, and competition
in the oligotrophic colonic environment.
A synbiotic result from the combination of a
probiotic and a prebiotic in a single product that is
used as a healthy dietary supplement in the restora-
tion and maintenance of colonic microbiota (Nova
et al., 2008). An exciting development in the field
of pet animals is that of synbiotics targeted to par-
ticular species. This has been attempted for the first
time with canine synbiotics. Five candidate lacto-
bacilli, L. acidophilus, L. murinus, L. reuteri, L.
mucosae, and L. rhamnosus were isolated from a
Labrador dog (Tzortzis et al., 2004). Three of these
strains, L. mucosae, L. acidophilus, and L. reuteri,
were then evaluated for their growth on various
carbohydrates and antimicrobial activity against
Salmonella enterica serotype typhimurium, en-
teropathogenic E. coli, and the toxin negative mu-
tant of E. coli O157:H7. Based on of these data, a
candidate synbiotic forms can be identified with ac-
tivity against specific target pathogens. This canine
synbiotic concept was taken further in an attempt
to manufacture a prebiotic targeted to a particular
probiotic organism.
Many different environmental factors may af-
fect the gut microbial ecology; these include diet,
medication, stress, age and general living condi-
tions. Knowledge of the gut microbiota and its in-
teractions has led to the development of dietary
strategies that serve to sustain, or even improve
normal gastrointestinal microbiology. However, it
is clear that microbiota management through diet
is achievable. Importantly, the scientific tools for
determining probiotic and prebiotic effects now
exist and should be exploited. This has led to a vi-
brant, global, functional food industry that is intro-
ducing new products for gut health into markets
targeted to pet animals. 
Methodological Approaches
The gastrointestinal microbiota comprises of a very
complex consortium of different types of microor-
ganisms. A major drawback is the fact that scien-
tific knowledge on gut bacteria is too scarce to
determine what is a ‘balanced’ microbiota or even
a ‘normal’ microbiota. The gut microbiota includes
microbial communities assembled on the mucosal
surfaces and in the lumen of the gut. These com-
munities include both native species, that perma-
nently colonize the tract-‘persistent’/‘resident’
strains, and a variable set of living microorganisms,
that transit temporarily through the tract-‘occa-
sional’/‘transient’ strains (Guarner and Malagelada,
2003). However, most bacteria in the gut are not
culturable and their phenotypic characteristics are
unknown. They are acquired after birth and initial
colonization largely depend on environmental fac-
tors. In addition, transient bacteria are continuously
acquired from the environment. Recent evidence
suggests that host genotype may influence the final
composition, which is host-specific and relatively
stable over time in a given individual (Zoetendal et
al., 2004).
Molecular tools based on 16S rDNA sequence
similarities such as fluorescent in situ hybridization
(FISH), denaturing gradient gel electrophoresis
(DGGE), quantitative dot blot hybridization, re-
striction fragment length polymorphism (RFLP)
and large scale 16S rDNA sequencing have helped
to overcome the limitations of conventional micro-
biological plating methods in studying the fecal mi-
crobiota composition. However, these tools are just
now beginning to be applied to understand the dy-
namics of this complex community, and its rela-
tionship to diet and gut health. So, there is a need
to understand both the limitations of the current
data and the importance of moving forward with
the best feasible molecular techniques.  
The application of ‘omics’ technologies, i.e. ge-
nomics (study of genome), nutrigenomics (study of
effects of diet on gene expression), transcriptomics
(study of mRNA), proteomics (study of expressed
proteins), metabolomics (study of metabolites), and
epigenomics (study of genome modification) rep-
resents perhaps the greatest opportunity and chal-
lenge to date for nutritionists and microbiologists
to elucidate the complex interactions between gut
microbiota and host (German and Young, 2004).
These biotechnological approaches are mainly tar-
geted at 4 levels: adequate nutrient supply, healthy
intestinal architecture, balanced microbiota com-
position and host-commensal interactions.
Adequate nutrient supply
Nutrigenomics puts forward a totally new approach
to the monitoring of biological phenomena, asso-
ciated with nutrition (Roberts et al., 2001, Ommen
van and Stierum, 2002). This new approach con-
sists of analysis of many minute, even discrete
changes associated with the genetic response to nu-
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tritive stimuli. This kind of approach requires prior
knowledge of unknown biochemical and physio-
logical effects, which are difficult to identify with
the help of the developed markers (a single gene, a
single protein or a single metabolite).
Healthy intestinal architecture
Mucosal surfaces represent the main sites in which
environmental microorganisms and antigens inter-
act with the host. In particular, the intestinal mu-
cosal surfaces are in continuous contact with a
heterogeneous population of microorganisms of the
endogenous as well as exogenous origin. More-
over, the intestinal morphology changes with nu-
tritional variations, stress, aging, and disease
conditions. Because the absorptive functions of the
intestine are related to its morphology, alteration in
morphology may predispose the intestine to func-
tional disorders. Villous height, crypt depth and ep-
ithelium thickness of intestinal segments are direct
representations of the intestinal environment and
may be used as indicators of gut health. These pa-
rameters can be measured by scanning electron mi-
croscopy (SEM) and by image analysis software,
Microsoft Olympus.
For the critical events in gut mucosal health
(e.g. cell proliferation or apoptosis), novel func-
tional biomarkers are also developed based on tran-
scriptomics. 
Balanced microbiota composition 
Only limited literature exists on the normal gut mi-
crobiota of pets (Rastall, 2004). So, challenges with
this approach include the difficulties of assessing
and sampling many regions of the gastrointestinal
tract without altering gene expression of microor-
ganisms and issues of variability between individ-
uals. Much of the information presently available
regarding colonic microbiota comes from studies
that employed conventional microbiological culti-
vation techniques based on agar plates. This poses
a problem, however, as colonic microbiota are
thought to contain a high level of biodiversity in-
cluding many species that cannot be cultured using
present techniques. Moreover, this approach is
rather laborious, time consuming and often inaccu-
rate. It is also limited in scope, as majorities of the
bacterial species present in feces are not culturable
using standard microbiological techniques. Conse-
quently, our picture of the intestinal microbiota has
been biased in favor of the more easily cultured
members of the community. Even among those that
are culturable, species identification by traditional
identification methods is often difficult, if not im-
possible; only a limited number of species has been
fully characterized. In order to overcome the limi-
tations associated with culturing techniques, mo-
lecular biological methods are increasingly being
applied to study the GI tract ecology .This uncul-
turable flora can only be characterized by using
DNA-based microbiology methods (Langendijk et
al., 1995, McCartney et al., 1996). Most of these
methods rely on amplification, detection, and/or se-
quencing of diagnostic regions of 16S rRNA genes
(Harmsen et al., 2000). This culture problem is par-
ticularly acute in studies on canines. A study con-
ducted by Greetham et al. (2002) illustrated the
unreliability of apparently selective agar media for
enumeration of canine fecal bacteria; many of the
selective media used did not support the growth of
the target population. The image of the canine gut
flora, then, is based largely on traditional methods
of investigation (Simpson et al., 2002). In one
study (Tzortzis et al., 2004); fluorescent in situ hy-
bridization (FISH) was used to describe the flora
of Labrador’s dog (Fig. 1). However, the most sig-
nificant aspect of the canine microbiota is the much
lower level of bifidobacteria found in canines than
in other animals due to their dietary habit. Accord-
ing to their diet, herbivores contain a higher num-
ber of bacterial phyla, while carnivores the fewest
number, and omnivores are at an intermediate level
(Ley et al., 2008).
Total genomic DNA hybridization method
It utilizes the whole genomes rather than small ge-
nomic regions to determine the degree of similarity
between two microbes. It formed the basis for mo-
lecular microbial phylogeny before the advent of
the 16S rDNA revolution.
Genus- and species-specific PCR primers
Use of 16S rDNA or rRNA and its encoding genes
as target molecules are one of the most widely used
approaches in ecological studies (Amann et al.,
1995). Specific PCR primers and probes can be de-
signed based on the variable regions of this mole-
cule to detect certain species or groups of bacteria.
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Numerous genus- and species-specific PCR
primers and probes have been developed for bifi-
dobacteria (Yamamoto et al., 1992, Langendijk et
al., 1995, Kaufmann et al., 1997, Matsuki et al.,
1999).
Species-specific primers and probes are excel-
lent tools for targeting certain Bifidobacterium spp.
in mixed populations, providing valuable help in
identification, which is laborious and sometimes
unreliable by phenotypic characterization. How-
ever, the use of specific primers and probes in eco-
logical studies rules out the possibility of finding
other than the target Bifidobacterium spp. possibly
also present in the sample. On the other hand,
genus-specific primers or probes can give a good
overall picture of the bifidobacterial population, but
no information is obtained about the species or
strain composition. Another way of utilizing the
rRNA sequence heterogeneity in microbial ecology
is to use universal bacterial PCR primers to amplify
a fragment of rRNA or rDNA and then separate the
obtained PCR products in a sequence specific man-
ner in temperature gradient gel electrophoresis
(TGGE) or denaturing gradient gel electrophoresis
(DGGE) (Muyzer et al., 1993, Muyzer and Smalla,
1998). The gut bacterial profiling obtained by
TGGE or DGGE represents the prominent bacteria
in the community. This technique has already been
successfully applied to monitor the bifidobacterial
communities in human fecal samples (Zoetendal et
al., 1998). Recently, genus-specific primers were
designed for Lactobacillus spp. and also used suc-
cessfully in combination with DGGE to analyze
communities of lactobacilli. This approach opens
new possibilities to follow the qualitative changes
in the bifidobacterial and lactobacilli populations
in response to probiotic or prebiotic administration
as well as to study the effect of age, genetic back-
ground and other factors on the composition and
diversity of these bacterial groups.
Species specific quantitative real time PCR:
Currently, traditional plating methods, conven-
tional PCR, and FISH are used for the enumeration
of lactobacilli. Traditional plating methods have
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Fig. 1: Overview of the canine colonic microbiota. 
(A): Bacterial groups were enumerated by selective media and confirmed by DGGE in adult Shepherd dogs (Simpson et al.,
2002).
(B): Bacterial groups were enumerated by FISH in adult Labrador dog (Tzortis et al., 2004).
some major disadvantages compared to modern
molecular techniques, such as insufficient selectiv-
ity and the presence of ‘non-culturable’ bacteria in
fecal samples (O’Sullivan, 2000). The FISH tech-
nique provides reliable quantitative data for phys-
iologically related groups of bacteria and detects
non-culturable organisms. It is currently used to
quantify the genus Lactobacillus in feces. How-
ever, with the commonly used FISH probe (S-G-
Lab-0158-a-A20) for quantification of the genus
Lactobacillus, genera such as Enterococcus, Pedio-
coccus, Weissella, Vagococcus, Leuconostoc, and
Oenococcus are also detected (Harmsen et al.,
1999). In addition, the detection limit of FISH is
rather high, which disables the quantification of
very low bacterial numbers present in fecal sam-
ples, for example, different Lactobacillus spp. The
conventional PCR is sufficiently sensitive for the
detection of the different Lactobacillus spp. (Song
et al., 2000, Walter et al., 2001). However, the con-
ventional PCR can only be used for semi quantita-
tive assessment, due to endpoint analyses
limitations such as the plateau phase (Morrison and
Gannon, 1994) and diminishing effects of differ-
ences in PCR product abundance (Mathieu-Daude
et al., 1996). Contemporary quantitative real-time
PCR allows the monitoring of the complete ampli-
fication and as a consequence, overcomes the lim-
itations correlated with endpoint analysis of the
PCR process. To follow the PCR process, the use
of specific fluorescently labeled probes or a minor-
groove binding dye, like SYBR Green, can be uti-
lized (Bustin, 2000). A major disadvantage of the
minor groove binding dye is that these bind non-
specifically to all double-stranded DNA and may
therefore, reduce the specificity of a PCR reaction.
For enumeration of the relatively small amounts of
the different Lactobacillus spp. in fecal samples du-
plex 5’nuclease assays were developed. These as-
says use a specific fluorescently labeled (TaqMan)
probe during the amplification to ensure a high
specificity as well as sensitivity. 
Microchip approach:
While the feasibility of it has been established, cur-
rently available chips are still limited in scope for
pets. These microchips are specifically designed to
analyze the human fecal microbiota.
Chromatography
The beneficial bacteria exert their action by secret-
ing enzymes. These enzymes of a particular bac-
terium can be purified from its cell extract by
anion-exchange chromatography, adsorption chro-
matography, and size-exclusion chromatography.
Apparent molecular masses can be judged by size-
exclusion chromatography and sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE). Moreover, the bacterial metabolites like
the total short chain fatty acids (SCFA) and their
fractions - acetate, propionate and butyrate concen-
trations can be determined by gas-liquid chro-
matography (GLC).
Pulsed-field gel electrophoresis
The health benefits imparted by probiotic bacteria
are strain specific, and not species or genus spe-
cific. This usually requires the presence of recep-
tors on the bacterial cell wall that permit
attachment to the gastrointestinal epithelium. This
strain or clonal relationship is determined by
pulsed-field gel electrophoresis. The results suggest
that a clone need not be present in a food in high
numbers to establish itself in the intestine. 
Microarrays
Short-chain fructo-oligosaccharides (scFOS) and
other prebiotics are used to stimulate selectively
the growth and activity of lactobacilli and bifi-
dobacteria in the colon. However, there is little in-
formation on the mechanisms whereby prebiotics
exert their specific effects upon such microorgan-
isms. To study the genomic basis of scFOS metab-
olism in Lactobacillus plantarum WCFS1,
two-color microarrays were used to screen for dif-
ferentially expressed genes when grown on scFOS
compared to glucose (control).
Denaturing gradient gel electrophoresis
(DGGE)
Both prebiotics (fructooligosaccharides) and pro-
biotics (Bifidobacterium lactis and Streptococcus
thermophilus) supplemented diets induced a signif-
icant reduction of Clostridium and Bacteroides spp.
compared to control diet, whereas prebiotics were
also able to reduce the number of coliforms and to
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increase the presence of Bifidobacterium spp.
DGGE analysis showed a significant increase of
16S rRNA gene fragments in rats fed with either
probiotics or prebiotics (Alejandra et al., 2005). 
Fluorescent in situ hybridization (FISH) and
terminal restriction fragment length polymor-
phism (t-RFLP)
Dinoto et al. (2006) determined the bacterial pop-
ulations in cecal samples of rats by FISH and ter-
minal restriction fragment length polymorphism
(t-RFLP). 
Host-commensal interactions
The ability of bacteria to communicate with each
other, and with the host, has been known for over
a quarter of a century. However, genetic and mo-
lecular tools have made it possible to isolate the
signals, study their mechanisms and potentially
manipulate their effects for promoting gut health.
The ability of probiotic organisms to affect host
gene expression has been demonstrated in different
systems. For example, the turning on of mucin ex-
pression by Lactobacillus spp. (Mack et al., 1999)
and by activating transcription factors involved in
cytokine signaling directly, leading to NF kβ acti-
vation, and indirectly via cytokines, leading to sig-
nal transducer and activator of transcription (STAT)
activation (Miettinen et al., 2000). Human genome
arrays now provide a means to study the effect of
introduction of a probiotic organism on host gene
expression. Such systems can document changes in
differential gene expression (Cox et al., 2001). In
addition, quantitative morphometrix (numbers of T
cells, B cells, macrophages, and peripheral lym-
phocyte sub populations like CD3, CD4, and CD8)
can provide a means to study the key gene events
changed with prebiotic use, thereby leading to
identification of site of action and molecules in-
volved. 
Communication between bacteria has also been
studied. One method involves molecules called au-
toinducers that are secreted by organisms to regu-
late gene expression and control behavior (Henke
and Bassier, 2004). In many lactic acid bacterial
strains, bacteriocins function as quorum sensing
molecules, in that they are produced, and are con-
trolled in a cell-density dependent manner, using a
secreted peptide-pheromone that can enable the or-
ganism to switch on bacteriocin production at times
when competition for nutrients is likely to become
more severe (Eijsink et al., 2002).
Conclusions
These molecular tools need to be validated and
standardized and should then be utilized to build a
database of the pet intestinal microbiota, which will
form the basis for determining the degree to which
the microbiota can be influenced by dietary alter-
ations. A concerted, multidisciplinary effort, incor-
porating molecular microbiology techniques in the
setting of well-designed prospective studies, is
needed to advance our knowledge of the complex
interactions between host and microbiota to the
point that we can design effective dietary interven-
tions. Ultimately, this should lead to clinical inter-
vention studies to determine if diet-induced
microbiota changes can reduce the risk of major
gastrointestinal disorders thereby maintaining gut
health. Such intensive studies will exploit many
new functional foods in the pet-care field.
Future Perspectives
Outcomes tested with feeding studies in pet ani-
mals are frequently based on targets used in human
research. The effectiveness of probiotics and pre-
biotics are likely to differ for different species,
based in part on varying nutritional needs. Human
probiotics have been used successfully in pet ani-
mals (Rastall, 2004), but a more effective approach
would likely be use of strains found naturally in the
target animal (Fuller, 1989). New bacterial genera
may be discovered to be effective probiotics in pet
animals. Understanding at the cellular level the in-
teractions of specific probiotics with other intes-
tinal bacteria and with different types of host cells
is fundamental to understanding how the probiotics
and indirectly prebiotics function, the basis for ob-
served effects on canine physiology. Genetic tech-
nologies will be essential to providing necessary
precision for revealing the secrets of probiotic and
prebiotic actions as well as driving invention of
strains with targeted functions.
Moreover, the focus of most experiments using
dogs has been narrow, with most groups focusing
on microbial populations rather than on indices of
gut health. Future research should aim at the estab-
lishment of accurate relationships among the com-
44
Lipismita Samal et al. / Journal of Advanced Veterinary Research 1 (2011) 38-46
position of the colonic microbiota, gut health and
clinical outcomes observed in the animal. The var-
ious molecular tools will lead to a comprehensive,
unbiased database documenting gastrointestinal
commensal bacteria- the canine microbiome. The
crucial component would be the development of a
metagenomic database of canine microbes, prefer-
ably all regions of the gut and all stages of microbe
development. In practice this can be achieved by
using magic angle spinning (MAS), nuclear mag-
netic resonance (NMR), high pressure liquid chro-
matography (HPLC) and mass spectroscopy (MS).
These techniques are well developed and are in-
deed being used to establish a metabolomics data-
base of the rat intestinal tract. This approach will
result in a tremendous increase of knowledge of the
physiology and genetics of disease, and it will pave
the way for defining the underlying molecular
mechanisms in health and disease associated with
GIT, and ultimately developing functional bio-
markers for assessing disease risk and for use in di-
etary trials in pet animals. The current culture
methods also need to be modified for pet animal
applications. A polyphasic strategy based on selec-
tive plate culture for screening and colony isola-
tion, with molecular techniques for speciation
should be used. 
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